CEO Albert Bourla said in a statement that the pill could drastically cut deaths and hospitalizations. The Biden adminstration is set to announce that it will order at least 10 million courses of the pill.

Vaccines from both drugmakers have been approved in the EU for children from 12 to 17 years of age. Elsewhere, Australia continues its battle against the delta variant. Follow DW for the latest.

Researchers say two shots of either BioNTech-Pfizer or AstraZeneca vaccines are highly effective against variants. Elsewhere, China has declined to follow an investigation into the virus's origins. Follow DW for more.

The Biovac Institute reached a deal with Pfizer to prepare and deliver vaccine doses for the continent. It comes amid an increase of cases in Africa, where just 2% of the population have received a first dose.

As the world continues to battle the effects of the coronavirus pandemic, health experts and several pharmaceutical companies have come up with vaccines to reduce the effects. Oxford-AstraZeneca vaccine has given a significant boost to the global fight and here are five key things to know about the controversial vaccine.

The decision by European Medicines Agency may allow countries to begin vaccinating before the end of the year. The vaccine's approval was widely expected, as EU nations grapple with a worsening coronavirus second wave.

US experts vote to recommend granting emergency approval for Pfizer-BioNTech's Covid-19 vaccine, paving the way for America to become the next country to move ahead with mass immunization as the country's virus death toll approaches 300,000. The US government's top infectious disease specialist Anthony Fauci also comments on the vaccine recommendation, saying "they are safe and they are highly effective, and those decisions were made by independent bodies without any political or other influence,".

Here are a few reasons to pick up a copy of The Guardian on Thursday. Find these stories and much more when you grab a copy of The Guardian on Thursday.⁣

Pfizer and BioNTech have lodged their COVID-19 vaccine with the European Medicines Agency for conditional approval. The companies have already taken similar steps in the US and UK.

Pfizer and BioNTec are preparing to submit their vaccine to US regulators for approval for emergency use. The two pharma firms claim the product is effective in 95% of the cases with no major safety concerns.

Here are a few reasons to pick up a copy of The Guardian on Saturday⁣. Find these stories and much more when you grab a copy of The Guardian on Saturday.⁣⁣

Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.